Q linea AB
STO:QLINEA

Watchlist Manager
Q linea AB Logo
Q linea AB
STO:QLINEA
Watchlist
Price: 23.8 SEK -1.24%
Market Cap: kr451m

Relative Value

The Relative Value of one QLINEA stock under the Base Case scenario is hidden SEK. Compared to the current market price of 23.8 SEK, Q linea AB is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

QLINEA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

QLINEA Competitors Multiples
Q linea AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Q linea AB
STO:QLINEA
451m SEK 53.7 -2.4 -2.5 -2.5
US
Abbott Laboratories
NYSE:ABT
189.6B USD 4.3 29.1 16.5 22.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
171B USD 17 59.8 45.5 55.1
US
Stryker Corp
NYSE:SYK
138.8B USD 5.5 42.9 21.7 26.3
IE
Medtronic PLC
NYSE:MDT
132.5B USD 3.8 27.8 15.6 22.5
US
Boston Scientific Corp
NYSE:BSX
115.7B USD 6 41.5 24.6 33.5
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD 2.7 35.1 12.8 21.9
DE
Siemens Healthineers AG
XETRA:SHL
45.8B EUR 2 21.5 12.2 17.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.8B USD 12 48.7 34.8 38.4
US
Edwards Lifesciences Corp
NYSE:EW
45.4B USD 7.7 33.2 23.6 25.8
US
Resmed Inc
NYSE:RMD
39B USD 7.2 26.2 18.5 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Q linea AB
STO:QLINEA
Average EV/EBITDA: 22.6
Negative Multiple: -2.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.5
24%
1.9
US
Stryker Corp
NYSE:SYK
21.7
12%
1.8
IE
Medtronic PLC
NYSE:MDT
15.6
8%
1.9
US
Boston Scientific Corp
NYSE:BSX
24.6
22%
1.1
US
Becton Dickinson and Co
NYSE:BDX
12.8
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.2
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.8
11%
3.2
US
Edwards Lifesciences Corp
NYSE:EW
23.6
13%
1.8
US
Resmed Inc
NYSE:RMD
18.5
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Q linea AB
STO:QLINEA
Average EV/EBIT: 28.4
Negative Multiple: -2.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.5
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.1
25%
2.2
US
Stryker Corp
NYSE:SYK
26.3
16%
1.6
IE
Medtronic PLC
NYSE:MDT
22.5
17%
1.3
US
Boston Scientific Corp
NYSE:BSX
33.5
32%
1
US
Becton Dickinson and Co
NYSE:BDX
21.9
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.2
15%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.4
11%
3.5
US
Edwards Lifesciences Corp
NYSE:EW
25.8
14%
1.8
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7